Nobilis Health(NRTSF)
$0.000.00 (0.00%)
NRTSF
Nobilis Health financials statements
$0.00
At close:0.00 (0.00%)
Nobilis Health (NRTSF) Ratios
11 Followers
Nobilis Health Ratios
NRTSF's free cash flow for Q2 2018 was $-634.00K. For the 2018 fiscal year, NRTSF's free cash flow was decreased by $-697.00K and operating cash flow was $63.00K. See a summary of the company’s cash flow.
| Ratios | Dec 17 |
|---|---|
| Liquidity Ratios | |
| Current Ratio | 2.12 |
| Quick Ratio | 2.08 |
| Cash Ratio | 0.26 |
| Solvency Ratio | 0.07 |
| Operating Cash Flow Ratio | 0.30 |
| Short-Term Operating Cash Flow Coverage | 3.29 |
| Net Current Asset Value | $ -48.52M |
| Leverage Ratios | |
| Debt-to-Assets Ratio | 0.32 |
| Debt-to-Equity Ratio | 0.91 |
| Debt-to-Capital Ratio | 0.48 |
| Long-Term Debt-to-Capital Ratio | 0.43 |
| Financial Leverage Ratio | 2.86 |
| Debt Service Coverage Ratio | 1.51 |
| Interest Coverage Ratio | 3.71 |
| Debt to Market Cap | 1.15 |
| Interest Debt Per Share | 1.83 |
| Net Debt to EBITDA | 3.34 |
| Profitability Margins | |
| Gross Profit Margin | 62.40% |
| EBIT Margin | 7.54% |
| EBITDA Margin | 11.41% |
| Operating Profit Margin | 7.44% |
| Pretax Profit Margin | 7.77% |
| Net Profit Margin | 1.27% |
| Continuous Operations Profit Margin | 3.43% |
| Net Income Per EBT | 16.31% |
| EBT Per EBIT | 104.36% |
| Return on Assets (ROA) | 0.88% |
| Return on Equity (ROE) | 2.52% |
| Return on Capital Employed (ROCE) | 6.49% |
| Return on Invested Capital (ROIC) | 2.78% |
| Return on Tangible Assets | 1.53% |
| Earnings Yield | 3.61% |
| Efficiency Ratios | |
| Receivables Turnover | 2.07 |
| Payables Turnover | 4.63 |
| Inventory Turnover | 33.58 |
| Fixed Asset Turnover | 5.81 |
| Asset Turnover | 0.70 |
| Working Capital Turnover Ratio | 3.07 |
| Cash Conversion Cycle | 108.12 |
| Days of Sales Outstanding | 176.00 |
| Days of Inventory Outstanding | 10.87 |
| Days of Payables Outstanding | 78.75 |
| Operating Cycle | 186.87 |
| Cash Flow Ratios | |
| Operating Cash Flow Per Share | 0.34 |
| Free Cash Flow Per Share | 0.27 |
| Dividend Paid and CapEx Coverage Ratio | 5.12 |
| Capital Expenditure Coverage Ratio | 5.12 |
| Operating Cash Flow Coverage Ratio | 0.19 |
| Operating Cash Flow to Sales Ratio | 0.09 |
| Free Cash Flow Yield | 20.21% |
| Valuation Ratios | |
| Price-to-Earnings (P/E) Ratio | 27.68 |
| Price-to-Sales (P/S) Ratio | 0.35 |
| Price-to-Book (P/B) Ratio | 0.70 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 4.95 |
| Price-to-Operating Cash Flow Ratio | 3.98 |
| Price-to-Earnings Growth (PEG) Ratio | -0.74 |
| Enterprise Value Multiple | 6.41 |
| Enterprise Value | 219.37M |
| EV to EBITDA | 6.41 |
| EV to Sales | 0.73 |
| EV to Free Cash Flow | 10.33 |
| EV to Operating Cash Flow | 8.31 |
| Tangible Book Value Per Share | 0.20 |
| Shareholders’ Equity Per Share | 1.93 |
| Tax and Other Ratios | |
| Effective Tax Rate | 0.56 |
| Revenue Per Share | 3.85 |
| Net Income Per Share | 0.05 |
| Tax Burden | 0.16 |
| Interest Burden | 1.03 |
| Research & Development to Revenue | 0.00 |
| SG&A to Revenue | 0.50 |
| Stock-Based Compensation to Revenue | 0.01 |
| Income Quality | 2.57 |
Currency in USD

